Enabling Subcutaneous Delivery For Improved Patient Compliance And Healthcare System Efficiencies
Source: Nanoform
Nanoform Biologics' new subcutaneous delivery platform promises to transform biologics administration. By overcoming key obstacles like volume constraints and protein clumping, their technology allows for highly concentrated, stable injections under the skin. This breakthrough could significantly improve patient access, adherence, and treatment effectiveness, offering a vital solution as the demand for biologics surges.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.
Subscribe to Drug Delivery Leader
X
Subscribe to Drug Delivery Leader